OGN:NYSE
Organon & Co
$13.74
arrow_downward
-0.07%(-0.0090) 1D
Sep 9, 10:17:29 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
$13.78
High
$13.78
Low
$13.74
Mkt. cap
3.61B
Avg. vol.
2.92M
Volume
105.43K
Dividend
0.58%
Quarterly dividend
$0.02
Ex-dividend date
Aug 14, 2026
P/E ratio
17.60
52-wk high
$13.78
52-wk low
$5.69
EPS
$0.78
Beta
1.52
Shares outstanding
262.61M
No. of employees
10K
Open
$13.78
High
$13.78
Low
$13.74
Mkt. cap
3.61B
Avg. vol.
2.92M
Volume
105.43K
Dividend
0.58%
Quarterly dividend
$0.02
Ex-dividend date
Aug 14, 2026
P/E ratio
17.60
52-wk high
$13.78
52-wk low
$5.69
EPS
$0.78
Beta
1.52
Shares outstanding
262.61M
No. of employees
10K
News stories
From web sources and news partners
pharma.economictimes.indiatimes.com
·
1 day ago
Sun Pharma gets ratings boost from Moody's, S&P over $11.75-bn Organon bid
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10K
Founded1923
HeadquartersJersey City, New Jersey, United States
SectorPharmaceutical industry
Websiteorganon.com